Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
FLUOROPHARMA MEDICAL, INC. See All Filings	D	2016-04-06 00:00:00 UTC
Amount To Be Raised $1,000,000 Associated Brokers / Dealers N/A CIK Number 0001402785 Filed Document 0001415889-16-005456 Exclusions or Exemptions 506b Accepted Date 2016-04-06 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Debt
FLUOROPHARMA MEDICAL, INC. See All Filings	D	2015-06-08 00:00:00 UTC
Amount To Be Raised $2,000,000 Associated Brokers / Dealers Merriman Capital, Inc. CIK Number 0001402785 Filed Document 0001415889-15-002006 Exclusions or Exemptions 506b Accepted Date 2015-06-08 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Debt
FLUOROPHARMA MEDICAL, INC. See All Filings	D	2014-07-28 00:00:00 UTC
Amount To Be Raised $2,000,000 Associated Brokers / Dealers Monarch Capital Group LLC CIK Number 0001402785 Filed Document 0001415889-14-002249 Exclusions or Exemptions 506b Accepted Date 2014-07-28 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Debt
FLUOROPHARMA MEDICAL, INC. See All Filings	D	2014-01-10 00:00:00 UTC
Amount To Be Raised $2,000,000 Associated Brokers / Dealers Monarch Capital Group LLC CIK Number 0001402785 Filed Document 0001415889-14-000109 Exclusions or Exemptions 506b Accepted Date 2014-01-10 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
FLUOROPHARMA MEDICAL, INC. See All Filings	D	2013-09-27 00:00:00 UTC
Amount To Be Raised $7,000,000 Associated Brokers / Dealers LifeTech Capital LLC and Monarch Capital Group LLC CIK Number 0001402785 Filed Document 0001415889-13-001905 Exclusions or Exemptions 506b Accepted Date 2013-09-27 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity